A Study to Gather Information About Rivaroxaban in Patients in Sweden With Cancer Who Also Have Thrombosis (OSCAR-SE)

Clinical trial NCT05150938 · COMPLETED

Trial details

NCT number: NCT05150938
Sponsor: Bayer
Status: COMPLETED
Study type: OBSERVATIONAL

Treatment of Venous Thromboembolism in Cancer Patients

Start date: 2022-03-18
Primary completion: 2023-02-28
Enrollment: 5737

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.